OpenAI vs. Anthropic: The Memo That Highlights AI Rivalry
OpenAI and Anthropic are locked in a high-stakes battle for AI dominance, with OpenAI recently criticizing Anthropic's…
ANALYSIS: Anthropic vs OpenAI: Enterprise Adoption Shifts
Anthropic's AI solutions, like Claude Code, are gaining traction in the U.S. enterprise market, challenging OpenAI's do…
Financial Regulators Evaluate Risks of Latest AI Model from Anthropic
Financial regulators in the UK are urgently assessing the systemic risks posed by Anthropic's new AI models, focusing o…
OpenAI Memo: Anthropic Accused of Overstating Revenue by $8B
OpenAI has publicly accused rival AI lab Anthropic of inflating its revenue by $8 billion, revealing a high-stakes comp…
Lagarde Endorses Anthropic's Caution on AI Release
European Central Bank President Christine Lagarde has praised Anthropic for its careful release of the AI model Mythos,…
OpenAI vs. Anthropic: Cyber Model Showdown
OpenAI and Anthropic are locked in a race to develop the most effective AI models for identifying and mitigating softwa…
Anthropic vs OpenAI: The Battle Over Illinois' AI Liability Bill
Illinois' AI Liability Bill (SB 3444) is sparking debate among industry giants. The bill aims to balance AI accountabil…
Trump Administration and Anthropic's AI Policy Meeting
AI is becoming a key factor in national security and procurement policies, as evidenced by a recent meeting between Tru…
Amazon's $25 Billion Investment in Anthropic
Amazon is pouring up to $25 billion into Anthropic, underscoring a monumental shift in AI infrastructure. This substant…
Anthropic's Mythos: Unauthorized Access and Cybersecurity Risks
Recent unauthorized access to Anthropic's Mythos AI model underscores the critical need for robust cybersecurity measur…
### Unauthorized Access Claimed to Anthropic's Mythos Cyber Tool
Unauthorized access has been claimed to Anthropic's advanced cybersecurity tool, Mythos, sparking a significant respons…
Exploring Anthropic's $900 Billion Funding
Anthropic is in the midst of talks to secure a monumental funding round that could set its valuation at an unprecedente…